BridgeBio touts kidney benefits for Attruby, differentiating from amyloidosis competitors

BridgeBio’s Attruby preserves kidney function in patients with transthyretin amyloidosis cardiomyopathy, an effect that is “distinct” from other drugs in this space, according to Jefferies.